Grants for County governments - Health

The CHEJ Small Grants Program for Tier 1 focuses on empowering small grassroots organizations and all-volunteer groups with annual budgets up to $50,000. These grants, ranging from $1,000 to $5,000, support local initiatives aimed at addressing environmental health harms caused by toxic substances in communities. The funding is particularly targeted at enhancing community leadership, building organizational capacity, and providing education and training related to environmental justice. This grant is ideal for grassroots groups that are deeply rooted in low-wealth and communities of color, driving change from within.

This funding opportunity provides resources to state and local health departments to improve data collection and implement prevention strategies aimed at reducing drug overdose deaths, particularly from opioids.

This funding opportunity provides financial support for U.S. higher education institutions and nonprofits to construct or modernize collaborative research facilities that enhance biomedical and HIV/AIDS research capabilities.

This FOA will support integrated, interdisciplinary research teams from prior BRAIN technology and/or integrated approaches teams, and/or new projects from the research community that focus on examining circuit functions related to behavior, using advanced and innovative technologies. The goal will be to support programs with a team science approach that can realize meaningful outcomes within 5-plus years. Awards will be made for 5 years, with a possibility of one competing renewal. Applications should address overarching principles of circuit function in the context of specific neural systems underlying sensation, perception, emotion, motivation, cognition, decision-making, motor control, communication, or homeostasis. Applications should incorporate theory-/model-driven experimental design and should offer predictive models as deliverables. Applications should seek to understand circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating relevant dynamic patterns of neural activity and by measuring the resulting behaviors and/or perceptions. Applications are expected to employ approaches guided by specified theoretical constructs, and are encouraged to employ quantitative, mechanistic models where appropriate. Applications will be required to manage their data and analysis methods in a prototype framework that will be developed and used in the proposed U19 project and exchanged with other U19 awardees for further refinement and development. Model systems, including the possibility of multiple species ranging from invertebrates to humans, can be employed and should be appropriately justified. Budgets should be commensurate with multi-component teams of research expertise including neurobiologists, statisticians, physicists, mathematicians, engineers, computer scientists, and data scientists, as appropriate - that seek to cross boundaries of interdisciplinary collaboration.

This funding opportunity supports U.S.-based researchers and organizations in discovering and developing natural products as potential agents for cancer prevention, focusing on safe and effective compounds.

This funding opportunity provides financial support to national organizations that will deliver tailored technical assistance to health centers across the U.S. to improve primary health care delivery and operational efficiency.

The Opioid Abatement Fund Council (OAFC) seeks to combat opioid overdoses in Texas by awarding funds to implement a statewide program that will distribute the opioid overdose reversal medication naloxone where it is needed most, and provide related training, including airway clearance techniques. The Texas Legislature created the OAFC in 2021 to ensure funds collected through lawsuits against pharmaceutical companies are used fairly and efficiently to combat the opioid crisis in Texas. The OAFC is made up of 13 appointed experts and the Texas Comptroller of Public Accounts (CPA) as the non-voting presiding officer. Grant Amount: Up to $25 million Up to $25 million is available for this grant opportunity: approximately $18.75 million for the purchase of naloxone and providing related training, with nearly $3.13 million for administrative costs and another $3.13 million for interventions in targeted counties. The expected term of the grant agreement is an initial two years, with three possible two-year renewal periods for a total project length of eight years. The grant recipient will receive funds on a reimbursement basis. Eligibility Texas governmental entities, nonprofit organizations and any entity registered with the Texas Secretary of State and eligible to conduct business in Texas are eligible to apply. Funding will be awarded to one applicant to implement the program statewide, but applicants may use qualified subcontractors or subgrantees. Companies that paid funds or currently are involved in opioid abatement lawsuits are disqualified from applying. Applicants and subcontractors must also not be subject to the general disqualifications, such as being included on the CPA debarred vendor’s list or having a conflict of interest with the OAFC. Grant applicants may submit a written request for CPA’s preliminary review of any potential conflict of interest by March 18, 2024, to OAFC.nofa@cpa.texas.gov. Application and Award Process Applicants must complete an application form, including fully developed and detailed proposals and budgets, through the OAFC’s grant management system by May 7, 2024. The internet browser that works best with the grant management system is Google Chrome. A mobile app is also available. Applications will go through a multi-stage selection process, including a risk review and evaluation by an independent peer review panel. After the review process is complete, the OAFC will vote on the final grant award. The grant recipient will be required to submit timely detailed status reports that cover the grant recipient’s and any subgrantee’s performance, expenditures and any additional information requested by the OAFC. CPA may also conduct site visits during the project and after project completion to monitor progress and assess the effectiveness of the program.

This funding opportunity supports clinician-scientists with doctoral degrees who are dedicated to conducting innovative research on pain management through basic experimental studies involving human participants.

This funding opportunity provides financial support to nonprofit organizations and local governments in Michigan for improving emergency shelters and expanding transitional housing programs to better assist individuals and families experiencing homelessness.

This funding opportunity supports innovative research to personalize probiotic therapies by identifying individual factors that influence how people respond to probiotics, ultimately aiming to improve health outcomes.

In alignment with Center for Disease Control (CDC) viral hepatitis goals and current epidemiology, the Illinois Department of Public Health Office of Disease Control Viral Hepatitis Program is requesting applications for Hepatitis B (HBV) outreach, education, and linkage to care programs targeting populations disproportionately impacted by hepatitis B (foreign born Asian and/or African immigrant or refugee population, and persons who use drugs (PWUD). Through the provision of outreach and education services, this funding seeks to increase the priority population(s)’s knowledge and awareness of hepatitis B, increase hepatitis B screening, link people who are chronically infected with hepatitis B into care and decrease viral hepatitis-related morbidity and mortality within priority populations. This funding opportunity will allow organizations to expand their reach through partnering with community partners focused on health equity to enhancing their ability to reach disproportionately affected populations at high risk for hepatitis B. The Initiative is funded through State of Illinois general revenue funding to establish relationship with stakeholders, individuals, and organizations for the purpose of providing Hepatitis B outreach and education programs to underserved foreign born Asian and African immigrant, refugee communities, and persons who use drugs (PWUD) with educational messaging and referral linkages to screening and vaccination services. In 2021, approximately 880,000 to 1.89 million people were living with chronic hepatitis B in the U.S. Chronic hepatitis B can lead to serious health problems, including cirrhosis, liver cancer, and death. Currently, data on the HBV seroprevalence among foreign born and refugee populations from Asian and African communities is not recorded systematically in the US. However, the prevalence of HBV among Asian and African immigrant, refugee communities tend to reflect the prevalence in their country of origin. HBV is highly prevalent (>8%) in East Asian, sub-Saharan African nations, and tend to have high rates of chronic viral hepatitis. The focus of any funded program shall not be screening and vaccination, or treatment efforts, but the outreach to, and the education of, the target population regarding Hepatitis B and referral and linkage opportunities for screening, vaccination, and treatment services. These populations face unique problems that place them at greater risk for Hepatitis B infection, mistrust of traditional western medicine, stigma associated with viral hepatitis, barriers to accessing medical care (Language, insurance, undocumented). Programs should be unique, culturally innovative to the specified target group, and increase ongoing efforts of the Department to eliminate the disparities in screenings, vaccinations, medical management, transmission, and overall health outcomes experienced by Asian and African immigrant, refugee communities, and persons who use drugs (PWUD) relative to Hepatitis B.

This funding opportunity supports innovative research projects aimed at improving health outcomes and reducing disparities for minority populations in the U.S. through short-term studies and pilot interventions.

This grant provides funding to a wide range of organizations, including governments and nonprofits, to strengthen health systems and improve HIV and tuberculosis control in Lesotho.

This funding opportunity provides financial support to U.S. institutions focused on improving minority health and reducing health disparities by enhancing research capacity, fostering investigator development, and promoting community engagement.

This funding opportunity provides resources to academic and biotech researchers to develop and advance new treatments for Substance Use Disorders through drug repurposing and repositioning strategies.

This grant provides funding to support projects that improve mental health services and treatment for individuals with serious mental illness in Montana, focusing on prevention, crisis intervention, and transitional support.

This funding opportunity provides financial support to organizations that develop and evaluate street medicine interventions aimed at improving healthcare access and outcomes for individuals living with HIV who are unsheltered or unstably housed.

This funding opportunity provides financial support to nonprofit organizations and local governments to develop and implement innovative programs that reduce falls among older adults and individuals with disabilities, particularly those facing economic or social challenges.

This funding opportunity supports a New York-based organization to improve tobacco use treatment across the state by providing resources, training, and coordination for health systems and regional partners.

This funding opportunity supports innovative research to explore how HIV infection alters immune metabolism and increases the risk of tuberculosis and hepatitis B, encouraging multidisciplinary teams to identify new treatment strategies and biomarkers.